GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » EV-to-Revenue

Mainz Biomed NV (Mainz Biomed NV) EV-to-Revenue : 14.14 (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Mainz Biomed NV's enterprise value is $12.67 Mil. Mainz Biomed NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.90 Mil. Therefore, Mainz Biomed NV's EV-to-Revenue for today is 14.14.

The historical rank and industry rank for Mainz Biomed NV's EV-to-Revenue or its related term are showing as below:

MYNZ' s EV-to-Revenue Range Over the Past 10 Years
Min: 12.38   Med: 102.6   Max: 2018.06
Current: 14.14

During the past 5 years, the highest EV-to-Revenue of Mainz Biomed NV was 2018.06. The lowest was 12.38. And the median was 102.60.

MYNZ's EV-to-Revenue is ranked worse than
86.1% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.23 vs MYNZ: 14.14

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Mainz Biomed NV's stock price is $0.5717. Mainz Biomed NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.06. Therefore, Mainz Biomed NV's PS Ratio for today is 10.21.


Mainz Biomed NV EV-to-Revenue Historical Data

The historical data trend for Mainz Biomed NV's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV EV-to-Revenue Chart

Mainz Biomed NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - 205.60 169.73 27.82

Mainz Biomed NV Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 169.73 126.60 91.69 56.91 27.82

Competitive Comparison of Mainz Biomed NV's EV-to-Revenue

For the Diagnostics & Research subindustry, Mainz Biomed NV's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mainz Biomed NV's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mainz Biomed NV's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mainz Biomed NV's EV-to-Revenue falls into.



Mainz Biomed NV EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Mainz Biomed NV's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=12.668/0.896
=14.14

Mainz Biomed NV's current Enterprise Value is $12.67 Mil.
Mainz Biomed NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mainz Biomed NV  (NAS:MYNZ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Mainz Biomed NV's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.5717/0.056
=10.21

Mainz Biomed NV's share price for today is $0.5717.
Mainz Biomed NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mainz Biomed NV EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mainz Biomed NV (Mainz Biomed NV) Business Description

Traded in Other Exchanges
Address
Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129
Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.